US Drug Recall Register
Class III · Low risk Terminated Initiated Mar 18, 2022 (4 years ago)

NETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.

What was recalled

NETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit contains Vial 1 (Reaction vial with lyophilized powder), 1 Single dose vial, consisting of 40 mcg of dotate, 5 mcg of 1,10-phenanthroline, 6 mcg of Gentisic acid, 20 mg of D-Mannitol, and Nitrogen; and Vial 2, 1 Single dose vial of reaction buffer, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc., by: Gipharma S.r.l., Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40

Recalling firm
Advanced Accelerator Applications USA, Inc.
NDC code
69488-001-40
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0747-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mannitol recalls

See all